In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

Natural killer (NK) receptor signaling can lead to reduced cytotoxicity by NK cells and cytolytic T lymphocytes (CTLs) in vitro. Whether T cells are inhibited in vivo remains unknown, since peptide antigen-specific CD8(+) T cells have so far not been found to express NK receptors in vivo. Here we de...

Full description

Bibliographic Details
Main Authors:	Speiser, D, Pittet, M, Valmori, D, Dunbar, R, Rimoldi, D, Liénard, D, MacDonald, H, Cerottini, J, Cerundolo, V, Romero, P
Format:	Journal article
Language:	English
Published:	1999

Similar Items

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
by: Speiser, D, et al.
Published: (1999)

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
by: Valmori, D, et al.
Published: (1999)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
by: Romero, P, et al.
Published: (1998)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
by: Valmori, D, et al.
Published: (2000)

An antigen-targeted approach to adoptive transfer therapy of cancer.
by: Valmori, D, et al.
Published: (1999)

Immune monitoring in cancer immunotherapy.
by: Romero, P, et al.
Published: (2000)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
by: Pittet, M, et al.
Published: (1999)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
by: Valmori, D, et al.
Published: (1999)

Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion.
by: MacDonald, H, et al.
Published: (1982)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
by: Valmori, D, et al.
Published: (1999)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
by: Valmori, D, et al.
Published: (2000)

Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.
by: Zanovello, P, et al.
Published: (1989)

Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells.
by: Young, N, et al.
Published: (1998)

Immunomodulatory Effects of Rhaphidophora Korthalsii Methanol Extract on Natural Killer Cell Activation and Cytolytic Activity
by: Yeap, Swee Keong
Published: (2010)

Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.
by: Anikeeva, N, et al.
Published: (2005)

Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo.
by: Chiu, C, et al.
Published: (2007)

Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12.
by: Eberl, G, et al.
Published: (1996)

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.
by: Lalvani, A, et al.
Published: (1998)

Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
by: Cerundolo, V, et al.
Published: (1987)

Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice.
by: Collavo, D, et al.
Published: (1984)

Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
by: Salio, M, et al.
Published: (2003)

Cytolytically active murine T-cell hybrids.
by: Nabholz, M, et al.
Published: (1980)

Harnessing Invariant Natural Killer T Cells to Abolish the Suppressive Activity of Myeloid-derived Suppressor Cells and Restore Melanoma-specific Immune Response
by: Cerundolo, V
Published: (2009)

Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients.
by: Cerundolo, V
Published: (2000)

Survivin-based recombinant overlapping peptides induce t lymphocyte cytotoxicity and prolong the survival in in vivo melanoma model
by: Zhang, Y, et al.
Published: (2023)

Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo.
by: Speiser, D, et al.
Published: (1996)

Immunotherapy of melanoma.
by: Smith, C, et al.
Published: (2001)

Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems.
by: Stinchcombe, J, et al.
Published: (2011)

Role of CD8 in aberrant function of cytotoxic T lymphocytes.
by: Kessler, B, et al.
Published: (1997)

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.
by: Dunbar, P, et al.
Published: (1999)

NAADP Activates two-pore channels on t cell cytolytic granules to stimulate exocytosis and killing
by: Davis, L, et al.
Published: (2012)

NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing.
by: Davis, L, et al.
Published: (2012)

Frequent MAGE mutations in human melanoma.
by: Caballero, O, et al.
Published: (2010)

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.
by: Ogg, G, et al.
Published: (1998)

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients.
by: Speiser, D, et al.
Published: (2010)

Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses.
by: Carlin, L, et al.
Published: (2001)

Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis
by: Chan, A, et al.
Published: (2005)

Linking inflammation to natural killer T cell activation
by: Salio, M, et al.
Published: (2009)

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
by: Palmowski, M, et al.
Published: (2002)

Visualizing inhibitory and excitatory synapse dynamics In vivo
by: Berry, Kalen P. (Kalen Paul)
Published: (2018)